Page 159 - EJMO-9-1
P. 159

Eurasian Journal of Medicine and
            Oncology
                                                                               Potential of flavonoids against glioblastoma



                   A                                       C













                   B                                         D














            Figure 2. 2D interactions between ligand and amino acid residues along with 3D conformation of ligands within the binding cavity. (A) Visual representation
            of Compound 2 within the binding pocket of AKT1 (3O96). (B) Visual representation of Compound 1 within the binding pocket of mTOR (PDB ID:
            5OQ4). (C) Visual representation of co-crystal ligand (CLL) within the binding pocket of AKT1 (PDB ID: 3O96). (D) Visual representation of CCL within
            the binding pocket of mTOR (PDB ID: 5OQ4).
            Abbreviation: PDB: Protein Data Bank.
            Table 4. Pharmacological evaluation of bioactive flavonoids (Compounds 1 and 2) based on various parameters, accessed
            through SwissADME
                                                   Physiochemical properties
            Compound     Molecular    No. of heavy   No. of rotatable   H‑bond acceptors  H‑bond donors  TPSA (Å)
                       weight (g/mol)   atoms          bonds
            1             286.24         21              1              6             4            111.13
            2             316.26         23              2              7             4            120.36
                                                        Lipophilicity
            Compound      Log P o/w    Log P o/w   Log P (WLOGP)      Log P o/w     Log P o/w   Consensus log P o/w
                                                       o/w
                         (iLOGP)      (XLOGP3)                       (MLOGP)      (SILICOS‑IT)
            1              1.86         2.53            2.28           −0.03         2.03           1.73
            2              1.59         1.94            2.29           −0.31         2.06           1.52
                                               Water solubility and medicinal chemistry
            Compound    Log S (ESOL)  Log S (Ali)  Log S (SILICOS‑IT)  PAINS        Brenk         Synthetic
                                                                                                 accessibility
            1              −3.71        −4.51           −3.82           1             1             3.02
            2              −3.41        −4.09           −3.94           1             1             3.28
                                                        Drug‑likeness
            Compound     Lipinski       Ghose          Veber           Egan       Bioavailability   Log K (cm/s)
                                                                                                     P
                                                                                     score
            1              Yes           Yes            Yes             Yes          0.55           −6.25
            2              Yes           Yes            Yes             Yes          0.55           −6.85
            Abbreviations: H-bond: Hydrogen Bond; Log: Logarithm; Log Kp: Skin permeability coefficient; Log S: Logarithm of solubility; o/w: Octanal-water
            partition; PAIN: Pan-Assay Interference Compound; TPSA: Total polar surface area.



            Volume 9 Issue 1 (2025)                        151                              doi: 10.36922/ejmo.5768
   154   155   156   157   158   159   160   161   162   163   164